Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PCV13 booster at 40 months in children previously enrolled in a PCV13 infant study
ISRCTN21841117Phase 3Completed
- Sponsor
- John Radcliffe Hospital
- Start
- Mar 2010
- Modality
- Vaccines & Immunotherapeutics
01
Overview
Phase 3, open-label, single-arm trial of pneumococcal 13-valent conjugate vaccine in pneumococcal disease, sponsored by John Radcliffe Hospital. Started Mar 2010; status: completed.
02
Drugs
pneumococcal 13-valent conjugate vaccine
03
Conditions
pneumococcal disease
Beyond the preview
Go deeper on ISRCTN21841117.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN21841117.